Sponsor pipeline

Alesta Therapeutics clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1/2

NCT ID	Title	Condition	Status	Updated
Phase 1/2
NCT07179640	A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in…	Hypophosphatasia (HPP)	Recruiting	2026-08-03

Get alerts when Alesta Therapeutics's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.